Fund Holdings — New Leaf Venture Partners, L.L.C.

Total Portfolio Value:
$114.26M
Total Bought:
$0
Total Sold:
$21.14M
Net Transaction:
-$21.14M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Arvinas, Inc.(ARVN)1,289,5211,289,5210$53.08M$53.23M46.59%+$154.7K
Edgewise Therapeutics, Inc.(EWTX)1,553,6611,553,6610$17.00M$28.34M24.80%+$11.34M
Deciphera Pharmaceuticals Inc576,975576,9750$9.31M$9.08M7.94%-$230.8K
Crinetics Pharmaceuticals Inc141,000141,0000$5.02M$6.60M5.78%+$1.58M
Rallybio Corporation(RLYB)3,301,6033,301,6030$7.89M$6.11M5.35%-$1.78M
Passage Bio, Inc.(PASG)2,497,9222,497,9220$2.52M$3.37M2.95%+$849.3K
Rocket Pharmaceuticals, Inc.(RCKT)118,242118,2420$3.54M$3.19M2.79%-$358.3K
Alector Inc339,569339,5690$2.71M$2.04M1.79%-$665.6K
Cogent Biosciences, Inc.(COGT)250,765250,7650$1.47M$1.69M1.47%+$210.6K
X4 Pharmaceuticals, Inc.(XFOR)335,000335,0000$281.4K$465.6K0.41%+$184.3K
Iterum Therapeutics PlcSHS97,08497,0840$191.3K$149.5K0.13%-$41.7K
Harpoon Therapeutics Inc1,859,1680-1,859,168$21.14M$0—-$21.14M
Page 1 of 1
New Leaf Venture Partners, L.L.C. — 13F Holdings — Q1 2024 | TickerTrail